We are here to help   +49 (0) 2241.255 15 0
  • 0Shopping Cart
  • Product Types
      • Coagulation Proteins
      • Enzymes
      • Cells and Media
      • Cytokines and Chemokines
      • COVID-19 / SARS-CoV-2
      • Molecular Biology
      • Stem Cells / iPSC
      • Adhesion Molecules
      • Tissue Dissociation
      • Matrix Proteins / Bioprinting
      • Gene Editing / CRISPR / TARGATT
  • Brands
  • Company
  • Services
  • Career
  • News
  • Contact
  • Menu Menu
Home |Products|Coagulation Proteins|Human Factor VIIa

Human Factor VIIa

Cat.-Nr.: HCVIIA-0031

Description

Human factor VII is a single chain plasma glycoprotein, and is a zymogen in its native form (1-4). Proteolytic activation of factor VII, yields the enzyme factor VIIa, which when bound to the integral membrane protein tissue factor, forms an enzyme complex that proteolytically converts factor X to factor Xa. This enzyme complex is best known as the extrinsic factor Xase (pronounced ten-ase) complex, since by virtue of its tissue factor component, it is composed of protein normally extrinsic to the plasma environment. The conversion of factor VII to factor VIIa is catalyzed by a number of proteases including thrombin, factor IXa, factor Xa, factor XIa, and factor XIIa. Rapid activation also takes place when factor VII is combined with tissue factor in the presence of calcium (5-9). This latter event is consistent with autocatalysis, and is likely initiated by a small amount of pre-existing factor VIIa. The activation reaction results in cleavage of the peptide bond between arginine 152 and isoleucine 153. The resulting factor VIIa consists of an NH2-derived light chain (Mr = 20,000), and a COOHterminal derived heavy chain (Mr = 30,000), which remain associated through a single disulfide bond (cys 135 – cys 262). The light chain contains the membrane binding “Gla domain”, while the heavy chain contains the catalytic domain. Unlike other serine proteases, factor VIIa alone is not readily inhibited by the antithrombin III/heparin complex. However, in the presence of tissue factor, antithrombin III/heparin exhibits significant inhibition of factor VIIa (6). Human factor VIIa is prepared from affinity purified factor VII, and purified by ion exchange chromatography. The purified protein is supplied in 50% (vol/vol) glycerol/H2O and should be stored at -20°C. The purity is determined by SDS-PAGE analysis, and activity is measured in a factor VII clotting assay.

  • SUPPLIER:

    Haematologic TechnologiesProlytix

  • STATUS:

    In Stock

  • SIZE:

    20 µg

  • Overview

Overview

  • Species: Human
  • Human Factors: Factor VII
  • Additional Attributes: Enzymes (Coagulation)
  • Formulation:50% (vol/vol) glycerol/H2O
  • Purity:>95%
  • Localization:Plasma
  • Mode of action:Enzyme component of the extrinsic factor X activating complex; also activates factor IX, thus by-passing the contact activation system.
  • Molecular Weight:50000
  • Extinction Coeff:13,9
  • Specific activity:12,000-36,000 units/mg
  • Activity:Specific activity is determined by Factor VII clotting assay (PT). One unit of activity is equivalent to the factor VII activity in one milliter of normal plasma
  • Structure:2 subunits; NH2-terminal derived light chain (Mr=20,000), COOH-terminal derived heavy chain (Mr=30,000), NH2-terminal gla-domain, two EGF domains

RELATED PRODUCTS


  • Human Factor V

  • Human Factor X

  • Human Factor Xa

  • Human Factor XIII

  • Imprint
  • Privacy policy
Human Factor X Human Factor VII
Scroll to top